Vaclova, Tereza
Grazini, Ursula
Ward, Lewis http://orcid.org/0000-0002-5087-6305
O’Neill, Daniel
Markovets, Aleksandra
Huang, Xiangning
Chmielecki, Juliann
Hartmaier, Ryan
Thress, Kenneth S.
Smith, Paul D. http://orcid.org/0000-0002-2812-5978
Barrett, J. Carl
Downward, Julian http://orcid.org/0000-0002-2331-4729
de Bruin, Elza C. http://orcid.org/0000-0002-8996-8354
Funding for this research was provided by:
Cancer Research UK (FC001070)
Wellcome Trust (FC001070)
Article History
Received: 17 June 2020
Accepted: 23 February 2021
First Online: 19 March 2021
Competing interests
: This work was supported by funding to J.D. from the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001070), the UK Medical Research Council (FC001070) and the Wellcome Trust (FC001070). T.V. and L.W. are fellows of the AstraZeneca postdoc programme. T.V., U.G., L.W., D.O.N., A.M., X.H., J.C., R.H., K.T., P.S., J.C.B. and E.C.d.B. are employees of AstraZeneca. L.W., D.O.N., A.M., X.H., J.C., R.H., K.T., P.S., J.C.B. and E.C.d.B. hold shares of AstraZeneca.